Unofficial. This site is an experimental reformatting of data published by NHS England. It is not endorsed by NHS England. Always check the official Data Uses Register before relying on anything here.

Investigating the impact of the Health in Pregnancy Grant on birth outcomes in England, 2009-2011

London School of Economics and Political Science (LSE) · Academic

Expired The latest version ended on 31 March 2026. The September 2026 register still lists the agreement, but its term has passed.

Reference
DARS-NIC-309029-P7H1D
Latest version
v2.2
Term of latest version
1 February 2023 to 31 March 2026
Start date
1 May 2020
Data controller
Sole Data Controller
Commercial purposes
No
Sublicensing
No
Files released to date
45

Why the data was released

Objective for processing

Data is requested to assess the impact of the Health in Pregnancy Grant on birthweight and prematurity in England.

This request to process HES data is made on the legal basis outlined in the GDPR, Article 6.1.(e). That is, this research establishes a task in the public interest as it is undertaken within the London School of Economics, and is necessary for the university to fulfil its function in the public interest (Article 6(1)(e)). The LSE considers this project to be a task in the public interest due to the potential societal implications of the policy being evaluated - the Health in Pregnancy Grant (2009-2011). It is also impossible to analyse the impact of the grant on prematurity without this data, as gestational age is unavailable elsewhere. In terms of processing special category data (such as ethnicity), the legal basis is Article 9(2)(j) - that is, the research is conducted for archival, research or statistical purposes that are in the public interest. The research is proportionate to the aim pursued (see below). The researchers have agreed to respect the right to data protection at all times, and will carry out suitable and specific measures to safeguard the fundamental rights and the interests of the data subject, including ensuring non-disclosive output and the maintenance of data protection measures when using the data.

This research establishes a public interest due to the societal implications of the policy under evaluation - the Health in Pregnancy Grant, 2009-2011. This grant was a lump sum of £190.00 given to all pregnant women in the UK from the third trimester of pregnancy, regardless of income or work status. In order to receive the grant, pregnant women had to make an appointment with their GP or midwife, when they would be invited to fill out a form. Participants would receive the money via a bank transfer within seven days. When the grant was introduced, policymakers made it clear that it had two main aims: first, to reduce low birthweight; second, to reduce prematurity. Both low birthweight and prematurity are associated with low-income and lack of funds during pregnancy for healthy nutrition and lifestyle.

The rationale of the grant, therefore, was that boosting women's incomes during pregnancy, would facilitate the purchase and consumption of healthier food, invest in healthy lifestyle choices and reduce any financial stress caused by having a baby (for example, the grant could help to cover the large one-off cost of buying a buggy). This would, the government argued, improve birthweight and reduce prematurity. The grant cost over £130 million pounds a year and is estimated to have affected over 700,000 pregnant women a year. It is therefore a matter of public significance both in terms of its human impact and its cost to the public purse. The grant was also abolished in 2011 specifically on the grounds that it was ineffective. No follow-up study of the grant was made, and take-up was not recorded.

A robust analysis of whether the grant was effective, therefore, is needed to investigate how public money is used, and whether it is being used efficiently and effectively. There is very strong evidence that health outcomes during pregnancy - birthweight and prematurity have a significant impact on future health, through childhood and adulthood. The grant was therefore seen as an early intervention policy which aimed to alleviate pressure on NHS services by reducing health problems throughout the lifecycle. By accessing the HES data, it is possible to identify whether the grant achieved this aim.

To assess the impact of the Health in Pregnancy Grant on birthweight and prematurity in England, the London School of Economics will use a methodology called a 'Regression Discontinuity Design' which makes use of the arbitrary eligibility rule that was attached to the grant: all babies with due dates on or after 6 April 2009-16 April 2011 were eligible.

This meant that if the mother had a due date of 5 April 2009, you were not eligible for the grant, but if you had a due date of 6 April 2009 you were. Since it is random whether you have a due date on 5 or 6 April, the LSE can make use of this to isolate the causal impact of the grant on birth outcomes. The methodology essentially mimics the setup of a randomised control trial, which is considered the gold standard in estimating the causal impact of policies. Expected week of birth (calculated using week of birth and gestational age) will be used as a proxy for whether an individual was likely to receive the grant or not.

The LSE researchers require data from 2006-2014 as this includes a 3-year window before and after the grant was introduced. This will enable the researchers to check whether there were any notable changes in birthweight or prematurity over the period and check that the methodology is valid.

The London School of Economics require NHS England to create a 'week of birth' variable. Initially, the researchers required a bespoke week of birth variable that is centred on the date of 6 April 2009. Under the initial dissemination the London School of Economics researchers realised that they require:

a) a slightly different week of birth variable in addition to the one London School of Economics currently have, which would be centred around 16 April 2011 (as this was the cut-off date for the abolition of the grant) and;

b) a binary ‘treatment’ variable equal to one if a baby’s expected date of delivery (EDD) was between 6 April 2009 and 16 April 2011 inclusive, and zero otherwise (as this captures the treatment eligibility rules for the Health in Pregnancy Grant). This is because the researchers need to be completely confident that the week of birth variable as currently provided is accurate as it is absolutely critical to their methodology, and given the confusion over delivery/birth episodes during historic data dissemination so far London School of Economics need to be confident that there are not any errors in the construction of the treatment variable.

Month of birth would be too large a category as it would not enable the researchers to precisely identify how close a baby’s due date was to the eligibility cut-off, and it would therefore significantly reduce the effectiveness of their methodology. Date of birth would be very fine-grained, by contrast, but it would be identifiable. Based on existing research using birth registrations data accessed through the ONS, the researchers have concluded that week of birth is a practicable alternative to using date of birth.’

The data subjects are women who gave birth in England from 2006-2012 and their babies. Since the grant had a cut-off eligibility date, all births before 6 April 2009 act as the control group.

The research builds on previous work conducted by the London School of Economics (LSE) using ONS Birth Registrations microdata (provided through the ONS's Secure Research Service). This work was awarded a Distinction and an academic prize as part of a Masters programme undertaken by one of the researchers at the LSE. This proposed follow up to the research has secured funding from the Social Policy Department at the LSE. It will be a standalone research project, unconnected to any wider programmes of work.

This is a small standalone project, which is funded and will be disseminated on its own. However, it does run alongside a similarly-themed, wider programme of work within the Centre for Analysis of Social Exclusion (CASE) at LSE on the impact of recent social policy changes on outcomes. The Funder will not place any restriction or limitations on any publications and there is no time restriction on the funding.

There is a separate NIHR funded research project of a broadly similar scope by Leyland et al (2017) that investigated the impact of the Health in Pregnancy Grant in Scotland which found no significant effects on birthweight. The proposed project will improve on this existing evidence for reasons both of methodology and of coverage. First, Leyland et al (2017) use an ‘interrupted time series’ methodology, which does not allow them to account for contemporary events that may have biased their results (in particular the economic crisis of 2008-09, which may have led to downward bias in their estimation of birthweight effects). By contrast, this project uses a regression discontinuity design which focuses on births just before and just after the eligibility cut-off, enabling more credible causal estimates to be drawn. Second, to date no research has been conducted in England about the impact of the Health in Pregnancy Grant. This project would fill this gap.

The dataset requested and the variables selected within it are essential for this research. The LSE researchers need access to anonymised, record-level data including crucially: week of birth of the baby, birthweight and gestational age. The ONS's birth registrations data do not include gestational age, so it is impossible to assess the impact of the grant on prematurity without the HES data.

'Week of birth' will be used to avoid having to use identifiable (full date of birth) in calculating due dates and to minimise the amount of data required. Due dates will be used as a proxy to separate the sample into a treatment and control group. Gestational age is needed for two reasons: first, to calculate due dates (in conjunction with week of birth); second, to construct an outcome variable for prematurity. Other important outcome variables are birthweight, first antenatal assessment date (to see whether the grant incentivised women to seek medical advice earlier during pregnancy), healthy neonate indicator, postnatal stay, neonatal level of care, and the well baby flag. Other useful variables to serve as controls are sex of the baby, birth status, number of babies, number of previous pregnancies, ethnic category, and mother's age at birth. To see whether the impact of the grant differed depending on levels of deprivation, the researchers also need access to the Index of Multiple Deprivation and Lower Super Output Area. This will enable them to see how the effect of the grant varied across different groups (by IMD, ethnicity, etc), given that it may have mattered more to more disadvantaged groups.

There is another grant available to qualifying mothers called the Sure Start Maternity Grant. The Sure Start Maternity Grant was introduced in 2000 as a means-tested cash transfer for women in receipt of benefits (by contrast, the Health in Pregnancy Grant was universal). The SSMG was expanded in April 2000, December 2000, and April 2002, before being restricted to first-born children only in April 2011. This separate grant has been considered as a potential contributor to the research outcomes. This project's methodology will enable LSE to disentangle the marginal effect of the Health in Pregnancy Grant and the Sure Start Maternity Grant due to the unique EDD cut-off that applied to the HPG (6 April 2009): no changes to SSMG were made at this cut-off. LSE will also be able to isolate the effect of the abolition of the HPG on 16 April 2011 from the restriction of the SSMG to the first-born child on 11 April 2011 by looking at effects separately for first-borns.

However, with the data requested under this Agreement, LSE will not be able to identify the effect of the introduction of the SSMG in 2000 (and its expansion later in 2000 and in 2002) on birthweight and compare with the effect of the HPG. This is something that is currently being considered by LSE.

‘In order to look at the abolition of the HPG in 2011, LSE need to take into account changes to another maternity grant paid during pregnancy, the Sure Start Maternity Grant. The Sure Start Maternity Grant was introduced in 2000 as a means-tested cash transfer for women in receipt of benefits (by contrast, the Health in Pregnancy Grant was universal) and later increased in value in April 2000, December 2000 and April 2002. It was then restricted to first-born children only in April 2011. The abolition of the two grants at almost exactly the same time (SSMG restriction from 11 April 2011 and HPG abolition from 16 April 2011) makes it difficult to fully disentangle the independent effects of the changes to the two grants. However, there are differences in how particular groups are affected by the two changes which make evaluation possible. Comparing families with babies born before 11 April 2011 to those born after 16 April 2011:

higher income parents lose the HPG (£190) and are unaffected by the SSMG.

lower income parents having a first child lose the HPG (£190) but retain the SSMG (£500).

lower income parents having a second child lose both grants (£690).

As the dataset contains information on parity and a rough proxy measure for low income (area deprivation) LSE are able to look at the HPG effect by looking at effects for first-borns only. By looking at effects for second and subsequent borns, LSE are able to examine the combined effect of loss of HPG and SSMG. It is expected that if effects exist, they will be bigger for families losing both grants, given the cash loss is more than three times greater than for HPG alone. Including the SSMG in the analysis therefore provides a valuable further check on results, as well as allowing LSE to make use of data for all babies, not only for first-borns.

LSE are aware that with the data requested under this Agreement, they will not be able to identify the effect of the introduction of the SSMG in 2000 (and its expansion later in 2000 and in 2002). This would anyway be difficult because the gradual increase of the grant in stages (increasing £100 each time) complicates attempts at evaluation.’

The purpose of the research cannot be achieved in a less intrusive way, as record-level data is necessary to implement this analysis of the impact of the grant on birthweight and prematurity. No identifiable or sensitive variables are being requested.

The data has not been narrowed by demographics (e.g. age), clinical factors (e.g. diagnosis/procedure) or live/singleton birth status, since the aims of the Health in Pregnancy Grant were broad-based and universal, and as such were intended to improve birth outcomes for all women and babies, regardless of these characteristics. The researchers would like to investigate and compare the impact of the grant on stillbirths, live births, and multiple births, as it may be that the grant affected these groups differently.

In terms of episodes, only maternity episodes are required - and specifically those variables that have been previously specified. The unborn child and neonatal records are fundamental to the purpose of this research as they enable the measurement of the health and status of the baby, which was the main target of the Health in Pregnancy Grant.

In selecting the necessary variables, the researchers have been careful to minimise the amount of fields necessary to achieve the purpose of the research. Indeed, the request does not include any identifiable/high risk field.

The data controller is the London School of Economics. Data is processed by the LSE Secure Research Computing Governance Group who are substantive employees of LSE within the secure environment. The VIRTUS datacentre provides physical storage of the data only. VIRTUS Holdco Ltd do not access data held under this agreement as they only supply the building. Therefore, any access to the data held under this agreement would be considered a breach of the agreement. This includes granting of access to the database(s) containing the data.

The research is funded by the Social Policy Department at the LSE, and their role will be to help publish the findings of the research. This will include a public seminar, and the publication of a free working paper and/or copy of a peer-reviewed journal article via LSE Research Online.

Processing activities

All organisations party to this agreement must comply with the data sharing framework contract requirements, including those regarding the use (and purposes of that use) by “personnel” (as defined within the data sharing framework contract i.e. employees, agents and contractors of the data recipient who may have access to that data).

There will be no flow of data from the London School of Economics into NHS England.

Under a previous iteration, pseudonymised HES Admitted Patient Care data flew from NHS England and contained special category data including baby's week of birth and health status.

There are and will be no subsequent data flows after the initial transfer of data from NHS England to the London School of Economics.

The data will be processed by the LSE Secure Research Computing Governance Group. Please note that VIRTUS is the hosting environment (the physical data centre) of the LSE Secure Research Environment - it is LSE’s off-site data centre, managed by VIRTUS as a third-party organisation. As such, it is only the physical bricks and mortar location of the server - the actual processing is done by the end user (LSE), who works remotely and analyses data on the server after connecting.

Once the data has been received to the LSE Secure Research Computing Governance Group, the data will then be analysed in the LSE Secure Research Computing Governance Group Environment, exclusively by the LSE researchers . All figures produced will be aggregate figures (e.g. coefficients, means) each figure contains a sufficient cell count (e.g. the ONS's requirement of 10) to avoid disclosure of patient data.

The data will be cleaned, with duplicate records removed, and missing values and outliers dropped in an appropriate manner. To implement the regression discontinuity design, the researchers will use the baby's week of birth and gestational age to create a new variable for their due date. This variable will be used to separate the sample into a control and treatment group, such that observations are classed in the treatment group if they have an expected week of birth between 6 April 2009 and 16 April 2011 inclusive, and they are in the control group otherwise.

The researchers will then implement the agreed methodology using econometric techniques within statistical software. The outcomes of the treatment and control group will be compared, enabling estimates to be reached of the causal impact of the Health in Pregnancy Grant.

Given the 3 year extension request LSE will delete the research data at the end of the DSA, in March 2026. This will enable LSE to respond to any critiques or peer-review of the research and to make the necessary adaptations. The data will be stored in the LSE Secure Research Computing Governance Environment with security arrangements in place at all times, and only the researchers will have access to the data.

Data is not being matched to publicly available data.

Both researchers accessing the data are ONS Accredited Researchers and have undergone training and assessment by the Office of National Statistics' Secure Research Service in data confidentiality and data protection. Both have experience using confidential sensitive microdata. Similarly, all employees of the LSE Secure Research Computing Governance Group who will be receiving and processing the data have undergone appropriate training.

Data will be accessed within the LSE Secure Research Computing Governance Environment at the LSE in London.

There will be no data linkage undertaken with NHS England data provided under this agreement that is not already noted in the agreement.

Data will only be accessed and processed by substantive employees of the LSE and will not be accessed or processed by any other third parties not mentioned in this agreement.

There will be no attempts made by the LSE to re-identify individuals involved in this project as there is no requirement to do so.

Expected output

The main output from the data analysis will be submissions to peer-reviewed academic journals, specifically the Journal of Health Economics and the Journal of Policy Analysis and Management.

All figures produced will be aggregate figures (e.g. coefficients, means) and the researchers will ensure that each figure contains a sufficient cell count (e.g. the ONS's requirement of 10) to avoid disclosure of patient data.

In addition to the peer-reviewed journal submission, the researchers intend to hold a public seminar at the Centre for Analysis of Social Exclusion (CASE) at the LSE at which the findings of the research will be presented to a range of stakeholders, policymakers and members of the public. The peer-reviewed journal articles are likely to require a fee from readers for access, but the full content will be made available for free via LSE Research Online, as part of LSE’s commitment to the Open Access model.

The researchers will also write blogs or other short articles summarising the findings to ensure they communicate the findings of the research to wider audiences, including interested groups and civil society. The researchers' ongoing research from ONS Birth Registrations data, now supported by the HES data analysed as part of this agreement, suggests the Health in Pregnancy Grant substantially improved infant health in England by increasing birthweight and reducing prematurity in England. In order to complete this research, the researchers require an extension to complete the peer-review process and support the dissemination of results.

In September 2022, LSE re-submitted a journal article on the preliminary findings from this data as part of a 'Revise and Resubmit' offer from the Journal of Health Economics. This article examines the impact of the introduction of the HPG in 2009. LSE is still waiting to hear back from the journal, and any further revisions will require access to the data. LSE are now writing a second paper which will use the HES data to examine the abolition of the HPG in 2011. The target date for submission of this article to a journal, and for the CASE seminar, is 2023. The peer-review process is long and unpredictable, so the researchers are applying for a 3-year extension in order to guarantee that maximum impact can be made from the research.

LSE will also disseminate outputs to relevant patient-focussed charities, including (but not limited to) BLISS, who work with families who have low birth weight babies. A list of patient-focussed charities to include in dissemination will be drawn up prior to publication.

All outputs will contain only data that is aggregated with small numbers suppressed in line with the HES Analysis Guide.

Expected measurable benefits

The dissemination of the data benefits the provision of health because the stated aim of the Health in Pregnancy Grant was to promote and improve healthy birthweight and to reduce prematurity. Given the long-term impact of low birthweight and prematurity on a range of child and adult health outcomes, this is an issue of crucial importance. Assessing whether the Health in Pregnancy Grant was, in fact, effective at boosting these health incomes is therefore important to health. If the researchers found, for example, that the grant was effective in promoting healthy birth outcomes, then one possible implication could be that the grant should be re-introduced in order to improve the health of the population. Indeed, so far the research is indicating that the grant led to significant improvements in infant health via larger birthweights and lower prematurity.

The grant interacted with health services, since it was conditional on attending an ante-natal check-up from 25 weeks, and there is some evidence to suggest that in Scotland the grant led pregnant women to seek health advice earlier in their pregnancy (Leyland et al., 2017). Using the 'first antenatal appointment' variable, the researchers are examining the impact of the grant on how early women seek medical help during pregnancy. An evaluation of the effectiveness of the grant, and the political implications of that analysis, are therefore directly relevant to health and maternity services.

The dissemination is in the public interest because the Health in Pregnancy Grant came at a significant fiscal cost to the public purse and was justified on the grounds of improving health outcomes. The public therefore have an interest in ascertaining whether that public money was well spent, and if so, whether the grant should be re-introduced to the public benefit.

The outputs (peer reviewed journal submission and public seminar) will expand the evidence base on the impact of the Health in Pregnancy Grant on birth outcomes. It is hoped that it will be used to inform current policy debates about public health and early intervention. The researchers are in contact with a range of Members of Parliament who were vocal about the grant, and plan to keep them updated about the findings of the research.

The findings of the research will also be communicated beyond academia to the public sphere and to citizens through engagement with politicians and stakeholders, a CASE seminar, writing blogs and articles, and social media.

It is anticipated that the outcome of the re-submission to a peer-reviewed journal and submission of the second paper to a journal will be in 2023-24.

The researchers' analysis so far indicates that the Health in Pregnancy Grant led to substantial improvements in infant health. One of the researchers has published a working paper based on the latest ONS and HES data analysis. In July 2021 this paper was given a ‘Revise and Resubmit’ offer from the Journal of Health Economics on the condition that it conducts further analyses using gestational age and antenatal health booking, both of which have now been completed with the help of the HES data in this application (latest version here: https://maryreader.com/publication/the-infant-health-effects-of-starting-universal-child-benefits-in-pregnancy-evidence-from-england-and-wales/the-infant-health-effects-of-starting-universal-child-benefits-in-pregnancy-evidence-from-england-and-wales.pdf). Decision-making by peer-review journals tends to be slow and we do not expect the outcome to be decided until early 2023. After this, there may be a further 'round' of revisions to make. The researchers therefore require an extension in order to secure publication of this research in a high-impact journal.

The researchers are now writing a second journal article which will focus on the abolition of the HPG in 2011 and will also explore the interaction with other government policies of this period, including another pregnancy cash grant, the Sure Start Maternity Grant. These pieces of academic research could have significant policy influence once published. Positive outcomes could encourage politicians to consider the re-introduction of the Health in Pregnancy Grant and other policies to support infant health.

The Health in Pregnancy Grant cost £130 million a year and is estimated to have affected over 700,000 pregnant women and their babies a year. If this research found that the grant was effective and it were to be re-introduced, it could therefore have significant implications both fiscally and in terms of patient health. Conversely, if the research found that the grant was not effective and it confirmed that its abolition in 2011 was justified, this would strengthen the argument that it was a wasteful use of public funds and consolidate efficiency savings within the NHS.

In terms of expanding the evidence base on the impact of the Health in Pregnancy Grant, that benefit would be achieved with the publication of the research in a peer-reviewed journal. In doing so, the research will expand the evidence on the impact of cash transfers during pregnancy on birth outcomes, which so far has been scarce in the UK. This would have implications for NHS maternity and GP services as well as long-term child health.

Benefits reported so far

Jan 2023 (v2): The data has not been processed enough to recognise any yielded benefits as of yet. In September 2022, LSE used the data to make a resubmission to the Journal of Health Economics, which is still in the peer review process. Once publication is confirmed, the researchers will focus on public dissemination to ensure that maximal public benefits are delivered. Extending this agreement will help these benefits to be realised.

Datasets on the latest version

Legal basis for provision: Health and Social Care Act 2012 – s261(2)(a)

Datasets approved under DARS-NIC-309029-P7H1D-v2.2
DatasetType of dataSensitivity FrequencyConfidential data
HES-ID to MPS-ID HES Admitted Patient Care Anonymised - ICO Code Compliant Non-Sensitive One-Off Does not include the flow of confidential data
Hospital Episode Statistics Admitted Patient Care (HES APC) Anonymised - ICO Code Compliant Non-Sensitive One-Off Does not include the flow of confidential data

Files released

Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.

Patient opt-outs were not applied to any of the 45 files released under this agreement, across every version. About opt-outs

No files recorded as released under the latest version. 45 were released under earlier versions, shown in the version history.

Version history

The register lists each renewal of this agreement as a separate row. This site has 3 versions.

DARS-NIC-309029-P7H1D-v2.2 1 February 2023 to 31 March 2026
Title
Investigating the impact of the Health in Pregnancy Grant on birth outcomes in England, 2009-2011
Commercial
No
Sublicensing
No
Datasets
2
Files released
0

Datasets: HES-ID to MPS-ID HES Admitted Patient Care; Hospital Episode Statistics Admitted Patient Care (HES APC)

What changed from DARS-NIC-309029-P7H1D-v1.5

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-309029-P7H1D-v1.5
FieldWasBecame
Start date2022-03-302023-02-01
End date2023-03-292026-03-31
HES-ID to MPS-ID HES Admitted Patient Care: legal basisHealth and Social Care Act 2012 - s261 - 'Other dissemination of information'Health and Social Care Act 2012 – s261(2)(a)
Hospital Episode Statistics Admitted Patient Care (HES APC): legal basisHealth and Social Care Act 2012 - s261 - 'Other dissemination of information'Health and Social Care Act 2012 – s261(2)(a)

Objective for processing

[1 paragraph unchanged] A resupply of data is requested due to problems with the data provided under the V0 Agreement. In particular, sex of the baby and the number of previous pregnancies was absent in the original data since data production focused on birth episodes of care rather than delivery episodes. Additionally, the researchers were not aware that selecting a particular field was necessary in order to obtain the selected IMD fields for all years. In the previous data release, the researchers received a bespoke week of birth variable that is centred on the date of 6 April 2009 as requested. However, in the re-dissemination the researchers require a) a slightly different week of birth variable in addition to the one they currently have, which would be centred around 16 April 2011 (as this was the cut-off date for the abolition of the grant) and b) a binary ‘treatment’ variable equal to one if a baby’s expected date of delivery (EDD) was between 6 April 2009 and 16 April 2011 inclusive, and zero otherwise (as this captures the treatment eligibility rules for the Health in Pregnancy Grant). This is because the researchers need to be completely confident that the week of birth variable as currently provided is accurate as it is absolutely critical to their methodology, and given the confusion over delivery/birth episodes during data production so far they need to be confident that there are not any errors in the construction of the treatment variable. [7 paragraphs unchanged] The London School of Economics require NHS Digital England to create a 'week of birth' variable. The Initially, the researchers required a bespoke week of birth variable that is required in order to calculate women’s due dates, since due dates were eligibility criteria for centred on the Health in Pregnancy Grant (all women with due dates date of 6 April 2009 - 16 April 2011 inclusive were eligible for 2009. Under the grant). initial dissemination the London School of Economics researchers realised that they require: a) a slightly different week of birth variable in addition to the one London School of Economics currently have, which would be centred around 16 April 2011 (as this was the cut-off date for the abolition of the grant) and; b) a binary ‘treatment’ variable equal to one if a baby’s expected date of delivery (EDD) was between 6 April 2009 and 16 April 2011 inclusive, and zero otherwise (as this captures the treatment eligibility rules for the Health in Pregnancy Grant). This is because the researchers need to be completely confident that the week of birth variable as currently provided is accurate as it is absolutely critical to their methodology, and given the confusion over delivery/birth episodes during historic data dissemination so far London School of Economics need to be confident that there are not any errors in the construction of the treatment variable. [9 paragraphs unchanged] ‘In order to look at the abolition of the HPG in 2011, LSE need to take into account changes to another maternity grant paid during pregnancy, the Sure Start Maternity Grant. The Sure Start Maternity Grant was introduced in 2000 as a means-tested cash transfer for women in receipt of benefits (by contrast, the Health in Pregnancy Grant was universal) and later increased in value in April 2000, December 2000 and April 2002. It was then restricted to first-born children only in April 2011. The abolition of the two grants at almost exactly the same time (SSMG restriction from 11 April 2011 and HPG abolition from 16 April 2011) makes it difficult to fully disentangle the independent effects of the changes to the two grants. However, there are differences in how particular groups are affected by the two changes which make evaluation possible. Comparing families with babies born before 11 April 2011 to those born after 16 April 2011: higher income parents lose the HPG (£190) and are unaffected by the SSMG. lower income parents having a first child lose the HPG (£190) but retain the SSMG (£500). lower income parents having a second child lose both grants (£690). As the dataset contains information on parity and a rough proxy measure for low income (area deprivation) LSE are able to look at the HPG effect by looking at effects for first-borns only. By looking at effects for second and subsequent borns, LSE are able to examine the combined effect of loss of HPG and SSMG. It is expected that if effects exist, they will be bigger for families losing both grants, given the cash loss is more than three times greater than for HPG alone. Including the SSMG in the analysis therefore provides a valuable further check on results, as well as allowing LSE to make use of data for all babies, not only for first-borns. LSE are aware that with the data requested under this Agreement, they will not be able to identify the effect of the introduction of the SSMG in 2000 (and its expansion later in 2000 and in 2002). This would anyway be difficult because the gradual increase of the grant in stages (increasing £100 each time) complicates attempts at evaluation.’ [6 paragraphs unchanged]

Processing activities

[1 paragraph unchanged] There will be no flow of data from the London School of Economics into NHS Digital. England. Pseudonymised Under a previous iteration, pseudonymised HES Admitted Patient Care data will flow flew from NHS Digital England and will contain contained special category data including baby's week of birth and health status. There are and will be no subsequent data flows after the initial transfer of data from NHS Digital England to the London School of Economics. [4 paragraphs unchanged] After Given the study has ended, the 3 year extension request LSE would like to store will delete the research data for a further 18 months and will apply for an extension to this Data Sharing Agreement. at the end of the DSA, in March 2026. This will enable LSE to respond to any critiques or peer-review of [10 words unchanged] will be stored in the LSE Secure Research Computing Governance Environment with the usual security arrangements in place at all times, and only the researchers will have access to the data. [3 paragraphs unchanged] There will be no data linkage undertaken with NHS digital England data provided under this agreement that is not already noted in the agreement. [2 paragraphs unchanged]

Expected output

The main output from the data analysis will be a submission submissions to peer-reviewed academic journals, specifically the Journal of Health Economics alternatively and the Journal of Public Health Policy Analysis and Management. [1 paragraph unchanged] In addition to the peer-reviewed journal submission, the researchers intend to hold [27 words unchanged] range of stakeholders, policymakers and members of the public. The peer-reviewed journal is articles are likely to require a fee from readers for access, but the full [9 words unchanged] Research Online, as part of LSE’s commitment to the Open Access model. The researchers may will also write blogs or other short articles summarising the findings to ensure [6 words unchanged] research to wider audiences, including interested groups and civil society. The researchers' preliminary ongoing research from ONS Birth Registrations data, now supported by the HES data analysed as part of this agreement, suggests the Health in Pregnancy Grant had a positive impact on birth weight substantially improved infant health in England by increasing birthweight and Wales. Findings from reducing prematurity in England. In order to complete this research will inform whether research, the Health in Pregnancy Grant was effective. researchers require an extension to complete the peer-review process and support the dissemination of results. The target date for the submission of the peer-reviewed journal and the CASE Seminar is 2022. In September 2022, LSE re-submitted a journal article on the preliminary findings from this data as part of a 'Revise and Resubmit' offer from the Journal of Health Economics. This article examines the impact of the introduction of the HPG in 2009. LSE is still waiting to hear back from the journal, and any further revisions will require access to the data. LSE are now writing a second paper which will use the HES data to examine the abolition of the HPG in 2011. The target date for submission of this article to a journal, and for the CASE seminar, is 2023. The peer-review process is long and unpredictable, so the researchers are applying for a 3-year extension in order to guarantee that maximum impact can be made from the research. LSE are will also looking to disseminate outputs to relevant patient-focussed charities, including (but not limited to) BLISS, [7 words unchanged] birth weight babies. A list of patient-focussed charities to include in dissemination is soon to will be drawn up. up prior to publication. [1 paragraph unchanged]

Expected measurable benefits

The dissemination of the data benefits the provision of health because the [91 words unchanged] be re-introduced in order to improve the health of the population. Indeed, so far the researchers' preliminary research using ONS Birth Registrations data indicates is indicating that the grant led to an approximate 20 gram increase significant improvements in average birthweight in England infant health via larger birthweights and Wales. lower prematurity. The grant interacted with health services, since it was conditional on attending an ante-natal check-up from 25 weeks, and there is some evidence to suggest that in Scotland the grant led pregnant women to [7 words unchanged] (Leyland et al., 2017). Using the 'first antenatal appointment' variable, the researchers will be able to examine are examining the impact of the grant on how early women seek medical help [14 words unchanged] of that analysis, are therefore directly relevant to health and maternity services. [3 paragraphs unchanged] It is anticipated that a submission the outcome of the re-submission to a peer-reviewed journal and submission of the second paper to a journal will be made in 2021, when a CASE seminar can also be held. 2023-24. Given The researchers' analysis so far indicates that the researchers' preliminary research from ONS Birth Registrations data suggests the Health in Pregnancy Grant had a positive impact on birth weight led to substantial improvements in England and Wales, it is anticipated that this will be mirrored with the HES data and possibly also hold for prematurity as an outcome. infant health. One of the researchers has published a working paper based on the latest ONS and HES data analysis (latest version here: https://maryreader.com/publication/the-birthweight-effects-of-universal-child-benefits-in-pregnancy-quasi-experimental-evidence-from-england-and-wales/the-birthweight-effects-of-universal-child-benefits-in-pregnancy-quasi-experimental-evidence-from-england-and-wales.pdf) analysis. In July 2021 this paper was given a ‘Revise and Resubmit’ offer from the Journal of Health [7 words unchanged] further analyses using gestational age and antenatal health booking, both of which can only be done have now been completed with the HES data. Hence the researchers need help of the HES data in this application (latest version here: https://maryreader.com/publication/the-infant-health-effects-of-starting-universal-child-benefits-in-pregnancy-evidence-from-england-and-wales/the-infant-health-effects-of-starting-universal-child-benefits-in-pregnancy-evidence-from-england-and-wales.pdf). Decision-making by peer-review journals tends to be slow and we do not expect the outcome to be decided until early 2023. After this, there may be a further 'round' of revisions to make. The researchers therefore require an extension in order to secure and publish publication of this research in this top-ranking a high-impact journal. The researchers also plan to write a further journal article exploring the drivers of the HPG’s impact on birthweight. These pieces of academic research could have significant policy influence once published. Positive outcomes could encourage politicians to consider the re-introduction of the Health in Pregnancy Grant. The researchers are now writing a second journal article which will focus on the abolition of the HPG in 2011 and will also explore the interaction with other government policies of this period, including another pregnancy cash grant, the Sure Start Maternity Grant. These pieces of academic research could have significant policy influence once published. Positive outcomes could encourage politicians to consider the re-introduction of the Health in Pregnancy Grant and other policies to support infant health. [1 paragraph unchanged] In terms of expanding the evidence base on the impact of the [6 words unchanged] would be achieved with the publication of the research in a peer-reviewed journal journal. In doing so, the research will expand the evidence on the impact of cash transfers during pregnancy on birth outcomes, which so far has been scarce in the UK. This would have implications for NHS maternity and GP services as well as long-term child health.

Benefits reported

Data was disseminated in late December 2020. The applicant has therefore not had sufficient time with the data to deliver any public benefits so far. However, data cleaning and analysis have begun and it is intended that extending this agreement will enable this work to yield the public benefits outlined above. Jan 2023 (v2): The data has not been processed enough to recognise any yielded benefits as of yet. In September 2022, LSE used the data to make a resubmission to the Journal of Health Economics, which is still in the peer review process. Once publication is confirmed, the researchers will focus on public dissemination to ensure that maximal public benefits are delivered. Extending this agreement will help these benefits to be realised.

DARS-NIC-309029-P7H1D-v1.5 30 March 2022 to 29 March 2023
Title
Investigating the impact of the Health in Pregnancy Grant on birth outcomes in England, 2009-2011
Commercial
No
Sublicensing
No
Datasets
2
Files released
36

Datasets: HES-ID to MPS-ID HES Admitted Patient Care; Hospital Episode Statistics Admitted Patient Care (HES APC)

What changed from DARS-NIC-309029-P7H1D-v0.7

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-309029-P7H1D-v0.7
FieldWasBecame
Start date2020-05-012022-03-30
End date2021-04-302023-03-29
Hospital Episode Statistics Admitted Patient Care (HES APC): legal basisHealth and Social Care Act 2012 – s261(2)(b)(ii)Health and Social Care Act 2012 - s261 - 'Other dissemination of information'

Datasets: + HES-ID to MPS-ID HES Admitted Patient Care

Objective for processing

This request to process HES data is made on the legal basis outlined in the GDPR, Article 6.1.(e). That is, this research establishes a task in the public interest as it is undertaken within the London School of Economics, and is necessary for the university to fulfil its function in the public interest (Article 6(e)). The LSE considers this project to be a task in the public interest due to the potential societal implications of the policy being evaluated - the Health in Pregnancy Grant (2009-2011). It is also impossible to analyse the impact of the grant on prematurity without this data, as gestational age is unavailable elsewhere. In terms of processing special category data (such as ethnicity), the legal basis is Article 9(2)(j) - that is, the research is conducted for archival, research or statistical purposes that are in the public interest. The research is proportionate to the aim pursued (see below). The researchers have agreed to respect the right to data protection at all times, and will carry out suitable and specific measures to safeguard the fundamental rights and the interests of the data subject, including ensuring non-disclosive output and the maintenance of data protection measures when using the data. Data is requested to assess the impact of the Health in Pregnancy Grant on birthweight and prematurity in England. A resupply of data is requested due to problems with the data provided under the V0 Agreement. In particular, sex of the baby and the number of previous pregnancies was absent in the original data since data production focused on birth episodes of care rather than delivery episodes. Additionally, the researchers were not aware that selecting a particular field was necessary in order to obtain the selected IMD fields for all years. In the previous data release, the researchers received a bespoke week of birth variable that is centred on the date of 6 April 2009 as requested. However, in the re-dissemination the researchers require a) a slightly different week of birth variable in addition to the one they currently have, which would be centred around 16 April 2011 (as this was the cut-off date for the abolition of the grant) and b) a binary ‘treatment’ variable equal to one if a baby’s expected date of delivery (EDD) was between 6 April 2009 and 16 April 2011 inclusive, and zero otherwise (as this captures the treatment eligibility rules for the Health in Pregnancy Grant). This is because the researchers need to be completely confident that the week of birth variable as currently provided is accurate as it is absolutely critical to their methodology, and given the confusion over delivery/birth episodes during data production so far they need to be confident that there are not any errors in the construction of the treatment variable. This request to process HES data is made on the legal basis outlined in the GDPR, Article 6.1.(e). That is, this research establishes a task in the public interest as it is undertaken within the London School of Economics, and is necessary for the university to fulfil its function in the public interest (Article 6(1)(e)). The LSE considers this project to be a task in the public interest due to the potential societal implications of the policy being evaluated - the Health in Pregnancy Grant (2009-2011). It is also impossible to analyse the impact of the grant on prematurity without this data, as gestational age is unavailable elsewhere. In terms of processing special category data (such as ethnicity), the legal basis is Article 9(2)(j) - that is, the research is conducted for archival, research or statistical purposes that are in the public interest. The research is proportionate to the aim pursued (see below). The researchers have agreed to respect the right to data protection at all times, and will carry out suitable and specific measures to safeguard the fundamental rights and the interests of the data subject, including ensuring non-disclosive output and the maintenance of data protection measures when using the data. [10 paragraphs unchanged] This is a small standalone project, which is funded and will be [44 words unchanged] limitations on any publications and there is no time restriction on the funding given that the work is due to be completed in July 2020. funding. There is a separate NIHR funded research project of a broadly similar scope by Leyland et al (2017) that investigated the impact of the Health in Pregnancy Grant in Scotland which found no significant effects on birthweight. The proposed project will improve on this existing evidence for reasons both of methodology and of coverage. First, Leyland et al (2017) use an ‘interrupted time series’ methodology, which does not allow them to account for contemporary events that may have biased their results (in particular the economic crisis of 2008-09, which may have led to downward bias in their estimation of birthweight effects). By contrast, this project uses a regression discontinuity design which focuses on births just before and just after the eligibility cut-off, enabling more credible causal estimates to be drawn. Second, to date no research has been conducted in England about the impact of the Health in Pregnancy Grant. This project would fill this gap. [2 paragraphs unchanged] There is another grant available to qualifying mothers called the Sure Start Maternity Grant. The Sure Start Maternity Grant was introduced in 2000 as a means-tested cash transfer for women in receipt of benefits (by contrast, the Health in Pregnancy Grant was universal). The SSMG was expanded in April 2000, December 2000, and April 2002, before being restricted to first-born children only in April 2011. This separate grant has been considered as a potential contributor to the research outcomes. This project's methodology will enable LSE to disentangle the marginal effect of the Health in Pregnancy Grant and the Sure Start Maternity Grant due to the unique EDD cut-off that applied to the HPG (6 April 2009): no changes to SSMG were made at this cut-off. LSE will also be able to isolate the effect of the abolition of the HPG on 16 April 2011 from the restriction of the SSMG to the first-born child on 11 April 2011 by looking at effects separately for first-borns. However, with the data requested under this Agreement, LSE will not be able to identify the effect of the introduction of the SSMG in 2000 (and its expansion later in 2000 and in 2002) on birthweight and compare with the effect of the HPG. This is something that is currently being considered by LSE. [4 paragraphs unchanged] The data controller is the London School of Economics. The Data Processor will be the LSE specifically is processed by the LSE Secure Research Computing Governance Group, whose Group who are substantive employees of LSE within the secure environment will be used for the data controllers to access the data. environment. The VIRTUS datacentre provides physical storage of the data only. VIRTUS Holdco Ltd do not access data held under this agreement as they only - supply the processing is conducted by LSE only. The research is funded by building. Therefore, any access to the Social Policy Department at the LSE, and their role will data held under this agreement would be to help publish the findings considered a breach of the research. agreement. This will include a public seminar, and includes granting of access to the publication of a free working paper and/or copy of a peer-reviewed journal article via LSE Research Online. database(s) containing the data. The research is funded by the Social Policy Department at the LSE, and their role will be to help publish the findings of the research. This will include a public seminar, and the publication of a free working paper and/or copy of a peer-reviewed journal article via LSE Research Online.

Expected output

[4 paragraphs unchanged] The target date for the submission of the peer-reviewed journal and the CASE Seminar is 2021. 2022. LSE are also looking to disseminate outputs to relevant patient-focussed charities, including (but not limited to) BLISS, who work with families who have low birth weight babies. A list of patient-focussed charities to include in dissemination is soon to be drawn up. [1 paragraph unchanged]

Expected measurable benefits

[6 paragraphs unchanged] Given that the researchers' preliminary research from ONS Birth Registrations data suggests [25 words unchanged] the HES data and possibly also hold for prematurity as an outcome. One of the researchers has published a working paper based on the ONS data analysis (latest version here: https://maryreader.com/publication/the-birthweight-effects-of-universal-child-benefits-in-pregnancy-quasi-experimental-evidence-from-england-and-wales/the-birthweight-effects-of-universal-child-benefits-in-pregnancy-quasi-experimental-evidence-from-england-and-wales.pdf) In July 2021 this was given a ‘Revise and Resubmit’ offer from the Journal of Health Economics on the condition that it conducts further analyses using gestational age and antenatal health booking, both of which can only be done with the HES data. Hence the researchers need the HES data to secure and publish this research in this top-ranking journal. The researchers also plan to write a further journal article exploring the drivers of the HPG’s impact on birthweight. These pieces of academic research could have significant policy influence once published. Positive outcomes could encourage politicians to consider the re-introduction of the Health in Pregnancy Grant. [2 paragraphs unchanged]

Benefits reported

Yielded Benefits is not a requirement for new applications. Data was disseminated in late December 2020. The applicant has therefore not had sufficient time with the data to deliver any public benefits so far. However, data cleaning and analysis have begun and it is intended that extending this agreement will enable this work to yield the public benefits outlined above.

Unchanged: Processing activities.

Objective for processing

Data is requested to assess the impact of the Health in Pregnancy Grant on birthweight and prematurity in England.

A resupply of data is requested due to problems with the data provided under the V0 Agreement. In particular, sex of the baby and the number of previous pregnancies was absent in the original data since data production focused on birth episodes of care rather than delivery episodes. Additionally, the researchers were not aware that selecting a particular field was necessary in order to obtain the selected IMD fields for all years.

In the previous data release, the researchers received a bespoke week of birth variable that is centred on the date of 6 April 2009 as requested. However, in the re-dissemination the researchers require a) a slightly different week of birth variable in addition to the one they currently have, which would be centred around 16 April 2011 (as this was the cut-off date for the abolition of the grant) and b) a binary ‘treatment’ variable equal to one if a baby’s expected date of delivery (EDD) was between 6 April 2009 and 16 April 2011 inclusive, and zero otherwise (as this captures the treatment eligibility rules for the Health in Pregnancy Grant). This is because the researchers need to be completely confident that the week of birth variable as currently provided is accurate as it is absolutely critical to their methodology, and given the confusion over delivery/birth episodes during data production so far they need to be confident that there are not any errors in the construction of the treatment variable.

This request to process HES data is made on the legal basis outlined in the GDPR, Article 6.1.(e). That is, this research establishes a task in the public interest as it is undertaken within the London School of Economics, and is necessary for the university to fulfil its function in the public interest (Article 6(1)(e)). The LSE considers this project to be a task in the public interest due to the potential societal implications of the policy being evaluated - the Health in Pregnancy Grant (2009-2011). It is also impossible to analyse the impact of the grant on prematurity without this data, as gestational age is unavailable elsewhere. In terms of processing special category data (such as ethnicity), the legal basis is Article 9(2)(j) - that is, the research is conducted for archival, research or statistical purposes that are in the public interest. The research is proportionate to the aim pursued (see below). The researchers have agreed to respect the right to data protection at all times, and will carry out suitable and specific measures to safeguard the fundamental rights and the interests of the data subject, including ensuring non-disclosive output and the maintenance of data protection measures when using the data.

This research establishes a public interest due to the societal implications of the policy under evaluation - the Health in Pregnancy Grant, 2009-2011. This grant was a lump sum of £190.00 given to all pregnant women in the UK from the third trimester of pregnancy, regardless of income or work status. In order to receive the grant, pregnant women had to make an appointment with their GP or midwife, when they would be invited to fill out a form. Participants would receive the money via a bank transfer within seven days. When the grant was introduced, policymakers made it clear that it had two main aims: first, to reduce low birthweight; second, to reduce prematurity. Both low birthweight and prematurity are associated with low-income and lack of funds during pregnancy for healthy nutrition and lifestyle.

The rationale of the grant, therefore, was that boosting women's incomes during pregnancy, would facilitate the purchase and consumption of healthier food, invest in healthy lifestyle choices and reduce any financial stress caused by having a baby (for example, the grant could help to cover the large one-off cost of buying a buggy). This would, the government argued, improve birthweight and reduce prematurity. The grant cost over £130 million pounds a year and is estimated to have affected over 700,000 pregnant women a year. It is therefore a matter of public significance both in terms of its human impact and its cost to the public purse. The grant was also abolished in 2011 specifically on the grounds that it was ineffective. No follow-up study of the grant was made, and take-up was not recorded.

A robust analysis of whether the grant was effective, therefore, is needed to investigate how public money is used, and whether it is being used efficiently and effectively. There is very strong evidence that health outcomes during pregnancy - birthweight and prematurity have a significant impact on future health, through childhood and adulthood. The grant was therefore seen as an early intervention policy which aimed to alleviate pressure on NHS services by reducing health problems throughout the lifecycle. By accessing the HES data, it is possible to identify whether the grant achieved this aim.

To assess the impact of the Health in Pregnancy Grant on birthweight and prematurity in England, the London School of Economics will use a methodology called a 'Regression Discontinuity Design' which makes use of the arbitrary eligibility rule that was attached to the grant: all babies with due dates on or after 6 April 2009-16 April 2011 were eligible.

This meant that if the mother had a due date of 5 April 2009, you were not eligible for the grant, but if you had a due date of 6 April 2009 you were. Since it is random whether you have a due date on 5 or 6 April, the LSE can make use of this to isolate the causal impact of the grant on birth outcomes. The methodology essentially mimics the setup of a randomised control trial, which is considered the gold standard in estimating the causal impact of policies. Expected week of birth (calculated using week of birth and gestational age) will be used as a proxy for whether an individual was likely to receive the grant or not.

The LSE researchers require data from 2006-2014 as this includes a 3-year window before and after the grant was introduced. This will enable the researchers to check whether there were any notable changes in birthweight or prematurity over the period and check that the methodology is valid.

The London School of Economics require NHS Digital to create a 'week of birth' variable. The week of birth variable is required in order to calculate women’s due dates, since due dates were eligibility criteria for the Health in Pregnancy Grant (all women with due dates of 6 April 2009 - 16 April 2011 inclusive were eligible for the grant).

Month of birth would be too large a category as it would not enable the researchers to precisely identify how close a baby’s due date was to the eligibility cut-off, and it would therefore significantly reduce the effectiveness of their methodology. Date of birth would be very fine-grained, by contrast, but it would be identifiable. Based on existing research using birth registrations data accessed through the ONS, the researchers have concluded that week of birth is a practicable alternative to using date of birth.’

The data subjects are women who gave birth in England from 2006-2012 and their babies. Since the grant had a cut-off eligibility date, all births before 6 April 2009 act as the control group.

The research builds on previous work conducted by the London School of Economics (LSE) using ONS Birth Registrations microdata (provided through the ONS's Secure Research Service). This work was awarded a Distinction and an academic prize as part of a Masters programme undertaken by one of the researchers at the LSE. This proposed follow up to the research has secured funding from the Social Policy Department at the LSE. It will be a standalone research project, unconnected to any wider programmes of work.

This is a small standalone project, which is funded and will be disseminated on its own. However, it does run alongside a similarly-themed, wider programme of work within the Centre for Analysis of Social Exclusion (CASE) at LSE on the impact of recent social policy changes on outcomes. The Funder will not place any restriction or limitations on any publications and there is no time restriction on the funding.

There is a separate NIHR funded research project of a broadly similar scope by Leyland et al (2017) that investigated the impact of the Health in Pregnancy Grant in Scotland which found no significant effects on birthweight. The proposed project will improve on this existing evidence for reasons both of methodology and of coverage. First, Leyland et al (2017) use an ‘interrupted time series’ methodology, which does not allow them to account for contemporary events that may have biased their results (in particular the economic crisis of 2008-09, which may have led to downward bias in their estimation of birthweight effects). By contrast, this project uses a regression discontinuity design which focuses on births just before and just after the eligibility cut-off, enabling more credible causal estimates to be drawn. Second, to date no research has been conducted in England about the impact of the Health in Pregnancy Grant. This project would fill this gap.

The dataset requested and the variables selected within it are essential for this research. The LSE researchers need access to anonymised, record-level data including crucially: week of birth of the baby, birthweight and gestational age. The ONS's birth registrations data do not include gestational age, so it is impossible to assess the impact of the grant on prematurity without the HES data.

'Week of birth' will be used to avoid having to use identifiable (full date of birth) in calculating due dates and to minimise the amount of data required. Due dates will be used as a proxy to separate the sample into a treatment and control group. Gestational age is needed for two reasons: first, to calculate due dates (in conjunction with week of birth); second, to construct an outcome variable for prematurity. Other important outcome variables are birthweight, first antenatal assessment date (to see whether the grant incentivised women to seek medical advice earlier during pregnancy), healthy neonate indicator, postnatal stay, neonatal level of care, and the well baby flag. Other useful variables to serve as controls are sex of the baby, birth status, number of babies, number of previous pregnancies, ethnic category, and mother's age at birth. To see whether the impact of the grant differed depending on levels of deprivation, the researchers also need access to the Index of Multiple Deprivation and Lower Super Output Area. This will enable them to see how the effect of the grant varied across different groups (by IMD, ethnicity, etc), given that it may have mattered more to more disadvantaged groups.

There is another grant available to qualifying mothers called the Sure Start Maternity Grant. The Sure Start Maternity Grant was introduced in 2000 as a means-tested cash transfer for women in receipt of benefits (by contrast, the Health in Pregnancy Grant was universal). The SSMG was expanded in April 2000, December 2000, and April 2002, before being restricted to first-born children only in April 2011. This separate grant has been considered as a potential contributor to the research outcomes. This project's methodology will enable LSE to disentangle the marginal effect of the Health in Pregnancy Grant and the Sure Start Maternity Grant due to the unique EDD cut-off that applied to the HPG (6 April 2009): no changes to SSMG were made at this cut-off. LSE will also be able to isolate the effect of the abolition of the HPG on 16 April 2011 from the restriction of the SSMG to the first-born child on 11 April 2011 by looking at effects separately for first-borns.

However, with the data requested under this Agreement, LSE will not be able to identify the effect of the introduction of the SSMG in 2000 (and its expansion later in 2000 and in 2002) on birthweight and compare with the effect of the HPG. This is something that is currently being considered by LSE.

The purpose of the research cannot be achieved in a less intrusive way, as record-level data is necessary to implement this analysis of the impact of the grant on birthweight and prematurity. No identifiable or sensitive variables are being requested.

The data has not been narrowed by demographics (e.g. age), clinical factors (e.g. diagnosis/procedure) or live/singleton birth status, since the aims of the Health in Pregnancy Grant were broad-based and universal, and as such were intended to improve birth outcomes for all women and babies, regardless of these characteristics. The researchers would like to investigate and compare the impact of the grant on stillbirths, live births, and multiple births, as it may be that the grant affected these groups differently.

In terms of episodes, only maternity episodes are required - and specifically those variables that have been previously specified. The unborn child and neonatal records are fundamental to the purpose of this research as they enable the measurement of the health and status of the baby, which was the main target of the Health in Pregnancy Grant.

In selecting the necessary variables, the researchers have been careful to minimise the amount of fields necessary to achieve the purpose of the research. Indeed, the request does not include any identifiable/high risk field.

The data controller is the London School of Economics. Data is processed by the LSE Secure Research Computing Governance Group who are substantive employees of LSE within the secure environment. The VIRTUS datacentre provides physical storage of the data only. VIRTUS Holdco Ltd do not access data held under this agreement as they only supply the building. Therefore, any access to the data held under this agreement would be considered a breach of the agreement. This includes granting of access to the database(s) containing the data.

The research is funded by the Social Policy Department at the LSE, and their role will be to help publish the findings of the research. This will include a public seminar, and the publication of a free working paper and/or copy of a peer-reviewed journal article via LSE Research Online.

Expected output

The main output from the data analysis will be a submission to peer-reviewed academic journals, specifically the Journal of Health Economics alternatively the Journal of Public Health

All figures produced will be aggregate figures (e.g. coefficients, means) and the researchers will ensure that each figure contains a sufficient cell count (e.g. the ONS's requirement of 10) to avoid disclosure of patient data.

In addition to the peer-reviewed journal submission, the researchers intend to hold a public seminar at the Centre for Analysis of Social Exclusion (CASE) at the LSE at which the findings of the research will be presented to a range of stakeholders, policymakers and members of the public. The peer-reviewed journal is likely to require a fee from readers for access, but the full content will be made available for free via LSE Research Online, as part of LSE’s commitment to the Open Access model.

The researchers may also write blogs or other short articles summarising the findings to ensure they communicate the findings of the research to wider audiences, including interested groups and civil society. The researchers' preliminary research from ONS Birth Registrations data suggests the Health in Pregnancy Grant had a positive impact on birth weight in England and Wales. Findings from this research will inform whether the Health in Pregnancy Grant was effective.

The target date for the submission of the peer-reviewed journal and the CASE Seminar is 2022.

LSE are also looking to disseminate outputs to relevant patient-focussed charities, including (but not limited to) BLISS, who work with families who have low birth weight babies. A list of patient-focussed charities to include in dissemination is soon to be drawn up.

All outputs will contain only data that is aggregated with small numbers suppressed in line with the HES Analysis Guide.

Benefits reported

Data was disseminated in late December 2020. The applicant has therefore not had sufficient time with the data to deliver any public benefits so far. However, data cleaning and analysis have begun and it is intended that extending this agreement will enable this work to yield the public benefits outlined above.

DARS-NIC-309029-P7H1D-v0.7 1 May 2020 to 30 April 2021
Title
Investigating the impact of the Health in Pregnancy Grant on birth outcomes in England, 2009-2011
Commercial
No
Sublicensing
No
Datasets
1
Files released
9

Datasets: Hospital Episode Statistics Admitted Patient Care (HES APC)

Objective for processing

This request to process HES data is made on the legal basis outlined in the GDPR, Article 6.1.(e). That is, this research establishes a task in the public interest as it is undertaken within the London School of Economics, and is necessary for the university to fulfil its function in the public interest (Article 6(e)). The LSE considers this project to be a task in the public interest due to the potential societal implications of the policy being evaluated - the Health in Pregnancy Grant (2009-2011). It is also impossible to analyse the impact of the grant on prematurity without this data, as gestational age is unavailable elsewhere. In terms of processing special category data (such as ethnicity), the legal basis is Article 9(2)(j) - that is, the research is conducted for archival, research or statistical purposes that are in the public interest. The research is proportionate to the aim pursued (see below). The researchers have agreed to respect the right to data protection at all times, and will carry out suitable and specific measures to safeguard the fundamental rights and the interests of the data subject, including ensuring non-disclosive output and the maintenance of data protection measures when using the data.

This research establishes a public interest due to the societal implications of the policy under evaluation - the Health in Pregnancy Grant, 2009-2011. This grant was a lump sum of £190.00 given to all pregnant women in the UK from the third trimester of pregnancy, regardless of income or work status. In order to receive the grant, pregnant women had to make an appointment with their GP or midwife, when they would be invited to fill out a form. Participants would receive the money via a bank transfer within seven days. When the grant was introduced, policymakers made it clear that it had two main aims: first, to reduce low birthweight; second, to reduce prematurity. Both low birthweight and prematurity are associated with low-income and lack of funds during pregnancy for healthy nutrition and lifestyle.

The rationale of the grant, therefore, was that boosting women's incomes during pregnancy, would facilitate the purchase and consumption of healthier food, invest in healthy lifestyle choices and reduce any financial stress caused by having a baby (for example, the grant could help to cover the large one-off cost of buying a buggy). This would, the government argued, improve birthweight and reduce prematurity. The grant cost over £130 million pounds a year and is estimated to have affected over 700,000 pregnant women a year. It is therefore a matter of public significance both in terms of its human impact and its cost to the public purse. The grant was also abolished in 2011 specifically on the grounds that it was ineffective. No follow-up study of the grant was made, and take-up was not recorded.

A robust analysis of whether the grant was effective, therefore, is needed to investigate how public money is used, and whether it is being used efficiently and effectively. There is very strong evidence that health outcomes during pregnancy - birthweight and prematurity have a significant impact on future health, through childhood and adulthood. The grant was therefore seen as an early intervention policy which aimed to alleviate pressure on NHS services by reducing health problems throughout the lifecycle. By accessing the HES data, it is possible to identify whether the grant achieved this aim.

To assess the impact of the Health in Pregnancy Grant on birthweight and prematurity in England, the London School of Economics will use a methodology called a 'Regression Discontinuity Design' which makes use of the arbitrary eligibility rule that was attached to the grant: all babies with due dates on or after 6 April 2009-16 April 2011 were eligible.

This meant that if the mother had a due date of 5 April 2009, you were not eligible for the grant, but if you had a due date of 6 April 2009 you were. Since it is random whether you have a due date on 5 or 6 April, the LSE can make use of this to isolate the causal impact of the grant on birth outcomes. The methodology essentially mimics the setup of a randomised control trial, which is considered the gold standard in estimating the causal impact of policies. Expected week of birth (calculated using week of birth and gestational age) will be used as a proxy for whether an individual was likely to receive the grant or not.

The LSE researchers require data from 2006-2014 as this includes a 3-year window before and after the grant was introduced. This will enable the researchers to check whether there were any notable changes in birthweight or prematurity over the period and check that the methodology is valid.

The London School of Economics require NHS Digital to create a 'week of birth' variable. The week of birth variable is required in order to calculate women’s due dates, since due dates were eligibility criteria for the Health in Pregnancy Grant (all women with due dates of 6 April 2009 - 16 April 2011 inclusive were eligible for the grant).

Month of birth would be too large a category as it would not enable the researchers to precisely identify how close a baby’s due date was to the eligibility cut-off, and it would therefore significantly reduce the effectiveness of their methodology. Date of birth would be very fine-grained, by contrast, but it would be identifiable. Based on existing research using birth registrations data accessed through the ONS, the researchers have concluded that week of birth is a practicable alternative to using date of birth.’

The data subjects are women who gave birth in England from 2006-2012 and their babies. Since the grant had a cut-off eligibility date, all births before 6 April 2009 act as the control group.

The research builds on previous work conducted by the London School of Economics (LSE) using ONS Birth Registrations microdata (provided through the ONS's Secure Research Service). This work was awarded a Distinction and an academic prize as part of a Masters programme undertaken by one of the researchers at the LSE. This proposed follow up to the research has secured funding from the Social Policy Department at the LSE. It will be a standalone research project, unconnected to any wider programmes of work.

This is a small standalone project, which is funded and will be disseminated on its own. However, it does run alongside a similarly-themed, wider programme of work within the Centre for Analysis of Social Exclusion (CASE) at LSE on the impact of recent social policy changes on outcomes. The Funder will not place any restriction or limitations on any publications and there is no time restriction on the funding given that the work is due to be completed in July 2020.

The dataset requested and the variables selected within it are essential for this research. The LSE researchers need access to anonymised, record-level data including crucially: week of birth of the baby, birthweight and gestational age. The ONS's birth registrations data do not include gestational age, so it is impossible to assess the impact of the grant on prematurity without the HES data.

'Week of birth' will be used to avoid having to use identifiable (full date of birth) in calculating due dates and to minimise the amount of data required. Due dates will be used as a proxy to separate the sample into a treatment and control group. Gestational age is needed for two reasons: first, to calculate due dates (in conjunction with week of birth); second, to construct an outcome variable for prematurity. Other important outcome variables are birthweight, first antenatal assessment date (to see whether the grant incentivised women to seek medical advice earlier during pregnancy), healthy neonate indicator, postnatal stay, neonatal level of care, and the well baby flag. Other useful variables to serve as controls are sex of the baby, birth status, number of babies, number of previous pregnancies, ethnic category, and mother's age at birth. To see whether the impact of the grant differed depending on levels of deprivation, the researchers also need access to the Index of Multiple Deprivation and Lower Super Output Area. This will enable them to see how the effect of the grant varied across different groups (by IMD, ethnicity, etc), given that it may have mattered more to more disadvantaged groups.

The purpose of the research cannot be achieved in a less intrusive way, as record-level data is necessary to implement this analysis of the impact of the grant on birthweight and prematurity. No identifiable or sensitive variables are being requested.

The data has not been narrowed by demographics (e.g. age), clinical factors (e.g. diagnosis/procedure) or live/singleton birth status, since the aims of the Health in Pregnancy Grant were broad-based and universal, and as such were intended to improve birth outcomes for all women and babies, regardless of these characteristics. The researchers would like to investigate and compare the impact of the grant on stillbirths, live births, and multiple births, as it may be that the grant affected these groups differently.

In terms of episodes, only maternity episodes are required - and specifically those variables that have been previously specified. The unborn child and neonatal records are fundamental to the purpose of this research as they enable the measurement of the health and status of the baby, which was the main target of the Health in Pregnancy Grant.

In selecting the necessary variables, the researchers have been careful to minimise the amount of fields necessary to achieve the purpose of the research. Indeed, the request does not include any identifiable/high risk field.

The data controller is the London School of Economics. The Data Processor will be the LSE specifically the LSE Secure Research Computing Governance Group, whose secure environment will be used for the data controllers to access the data. The VIRTUS datacentre provides physical storage of the data only - the processing is conducted by LSE only. The research is funded by the Social Policy Department at the LSE, and their role will be to help publish the findings of the research. This will include a public seminar, and the publication of a free working paper and/or copy of a peer-reviewed journal article via LSE Research Online.

Expected output

The main output from the data analysis will be a submission to peer-reviewed academic journals, specifically the Journal of Health Economics alternatively the Journal of Public Health

All figures produced will be aggregate figures (e.g. coefficients, means) and the researchers will ensure that each figure contains a sufficient cell count (e.g. the ONS's requirement of 10) to avoid disclosure of patient data.

In addition to the peer-reviewed journal submission, the researchers intend to hold a public seminar at the Centre for Analysis of Social Exclusion (CASE) at the LSE at which the findings of the research will be presented to a range of stakeholders, policymakers and members of the public. The peer-reviewed journal is likely to require a fee from readers for access, but the full content will be made available for free via LSE Research Online, as part of LSE’s commitment to the Open Access model.

The researchers may also write blogs or other short articles summarising the findings to ensure they communicate the findings of the research to wider audiences, including interested groups and civil society. The researchers' preliminary research from ONS Birth Registrations data suggests the Health in Pregnancy Grant had a positive impact on birth weight in England and Wales. Findings from this research will inform whether the Health in Pregnancy Grant was effective.

The target date for the submission of the peer-reviewed journal and the CASE Seminar is 2021.

All outputs will contain only data that is aggregated with small numbers suppressed in line with the HES Analysis Guide.

Benefits reported

Yielded Benefits is not a requirement for new applications.

Register history

When this agreement appeared in, or was edited in, each monthly edition of the register. Built by comparing every edition this site holds, the earliest of which is July 2021.

Cite this page

NHS England (2026) Data Uses Register, September 2026 edition, agreement DARS-NIC-309029-P7H1D, “Investigating the impact of the Health in Pregnancy Grant on birth outcomes in England, 2009-2011”. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/agreements/dars-nic-309029-p7h1d/ (accessed [date]).

This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.

Source: datausesregister_september2026.xlsx, September 2026 edition of the NHS England Data Uses Register. Search that workbook for DARS-NIC-309029-P7H1D to see the original rows.